Roche: Q1 Sales Results (Roche) - Apr 26, 2015 - Anticipated NME submission for platinum-resistant ovarian cancer in US in 2018 or later; Anticipated submission for platinum resistant ovarian cancer in EU in 2018 or later
Anticipated EU regulatory • Anticipated sBLA • Oncology • Ovarian Cancer
|